These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20804097)

  • 1. [Renal replacement therapy in adult dominant polycystic kidney disease--multicentre study].
    Lezaić V; Ostrić V; Popović G; Vukoje M; Dragolić B; Kostić N; Stojanović M; Labudović M; Mandić M; Djordjević V; Baković J
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():287-93. PubMed ID: 20804097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
    Christophe JL; van Ypersele de Strihou C; Pirson Y
    Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome of renal transplantation in patients with autosomal dominant polycystic kidney disease].
    Vega J; Lira D; Medel S; Betancour P; Goecke H; Carrasco A
    Rev Med Chil; 2012 Aug; 140(8):990-8. PubMed ID: 23282771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral nephrectomy versus renal arterial embolization and technique survival in peritoneal dialysis patients with autosomal dominant polycystic kidney disease.
    Pierre M; Moreau K; Braconnier A; Kanagaratnam L; Lessore De Sainte Foy C; Sigogne M; Béchade C; Petrache A; Verger C; Frimat L; Duval-Sabatier A; Caillard S; Halin P; Touam M; Issad B; Vrtovsnik F; Petitpierre F; Lobbedez T; Touré F
    Nephrol Dial Transplant; 2020 Feb; 35(2):320-327. PubMed ID: 31747008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease.
    Pirson Y; Christophe JL; Goffin E
    Nephrol Dial Transplant; 1996; 11 Suppl 6():24-8. PubMed ID: 9044324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal Dominant Polycystic Kidney Disease Transplant Recipients After Kidney Transplantation: A Single-center Experience.
    Illesy L; Kovács DÁ; Szabó RP; Asztalos L; Nemes B
    Transplant Proc; 2017 Sep; 49(7):1522-1525. PubMed ID: 28838432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
    Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of autosomal dominant polycystic kidney disease patients on peritoneal dialysis: a national retrospective study based on two French registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
    Sigogne M; Kanagaratnam L; Dupont V; Couchoud C; Verger C; Maheut H; Hazzan M; Halimi JM; Barbe C; Canivet E; Petrache A; Dramé M; Rieu P; Touré F
    Nephrol Dial Transplant; 2018 Nov; 33(11):2020-2026. PubMed ID: 29361078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience.
    Rabbani MA; Ali SS; Murtaza G; Ahmad B; Maria Q; Siddiqui BK; Shah SM; Ahmad A
    J Pak Med Assoc; 2008 Jun; 58(6):305-9. PubMed ID: 18988388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Abad JM; Aresté N; de la Torre RA; Caskey F; Couchoud C; Finne P; Heaf J; Hoitsma A; de Meester J; Pascual J; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ;
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4(Suppl 4):iv15-25. PubMed ID: 25165182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation in autosomal dominant polycystic kidney disease without nephrectomy.
    Knispel HH; Klän R; Offermann G; Miller K
    Urol Int; 1996; 56(2):75-8. PubMed ID: 8659014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation.
    Sulikowski T; Tejchman K; Zietek Z; Rózański J; Domański L; Kamiński M; Sieńko J; Romanowski M; Nowacki M; Pabisiak K; Kaczmarczyk M; Ciechanowski K; Ciechanowicz A; Ostrowski M
    Transplant Proc; 2009; 41(1):177-80. PubMed ID: 19249508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of renal transplantation in polycystic kidney disease.
    Stiasny B; Ziebell D; Graf S; Hauser IA; Schulze BD
    Clin Nephrol; 2002 Jul; 58(1):16-24. PubMed ID: 12141402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.
    Gonçalves S; Guerra J; Santana A; Abreu F; Mil-Homens C; Gomes da Costa A
    Transplant Proc; 2009 Apr; 41(3):887-90. PubMed ID: 19376380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study.
    Janeiro D; Portolés J; Tato AM; López-Sánchez P; Del Peso G; Rivera M; Castellano I; Fernández-Reyes MJ; Pérez-Gómez V; Ortega M; Martínez-Miguel P; Felipe C; Caparrós G; Ortiz A; Selgas R;
    Perit Dial Int; 2015; 35(5):530-6. PubMed ID: 25292408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant polycystic kidney disease in a kidney transplant population.
    Hadimeri H; Nordén G; Friman S; Nyberg G
    Nephrol Dial Transplant; 1997 Jul; 12(7):1431-6. PubMed ID: 9249781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations.
    Demetriou K; Tziakouri C; Anninou K; Eleftheriou A; Koptides M; Nicolaou A; Deltas CC; Pierides A
    Nephrol Dial Transplant; 2000 Feb; 15(2):205-11. PubMed ID: 10648666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.